Page 3 girl

Magic Bud is a fine blend of Indica and Sativa. This plant produces beautiful resin coated nugs in a relatively short time, approximately 56 days indoors. Her appealing velvet looks during flowering are a pleasure for the eye, and you have to be careful that you (or your friends) do not give into the urge to cut of a branch before she is fully ripened! Your patience will be royally rewarded with very tasty aromatic buds.

When dried and cured the Magic smokes smooth with a pleasant floral aromatic taste. The body relaxing effect combined with a strong potent high is magical, you will feel at ease with everything you do.

Type: Indica/ Sativa Flowering time: Approx 56 days indoors. Outdoors Middle of October (n.L.) Yield: 400 grams per m2 indoors. Outdoors approx. 500 grams per plant Suitable environments: Indoors. Outdoors between 50º n.L. and 50º s.L. Effects/Buzz: Pleasant Sativa-Indica high Smell/Taste: Floral -aromatic THC: 12-15%

Photo: Paradise Seeds

Magic Bud

Continued from front page

"Eradication of production and criminalization of consumption did not reduce drug traffic and drug use," the commission said. The harm from corruption and violence resulting from prohibition "largely exceeds the harm caused by drugs," the statement says.

Drug law reformers will be looking forward to seeing the commission's report this summer. The report from the Latin American Commission helped stir debate and advance the cause of reform.

Christian who says family life can beat addiction is new Government drugs adviser

The relatively soft approach to cannabis by the UK Government’s drugs advisers in recent years appears likely to change following the appointment in January of a Christian GP who takes a hard line against toking and says strong families can help to defeat alcohol and other addictions.

Dr Hans-Christian Raabe, a member of an international Christian movement who has been appointed to sit on the Advisory Council on the Misuse of Drugs, says children should simply be taught to say no.

His appointment to the ACMD signals a shake-up for the panel, which has clashed with ministers in recent years. Under Labour, the panel twice said cannabis should be a Class C rather than Class-B drug. Other advice has concentrated on reducing the harm to users by giving them the materials needed to take drugs more safely.

But Dr Raabe, who will represent GPs on the committee, promises a return to the stern prohibitionist approach. He holds views strongly at odds with former ACMD chairman Professor David Nutt, who believes that prohibition has failed and wants a new approach to classification based on the harm that each drug poses.

Nutt was sacked in October 2009 for saying cannabis was less harmful than alcohol and nicotine.

“The appointment of Dr Raabe confirms in my mind that the ACMD cannot be considered to be a body that has science at the heart of its decisionmaking,” said Professor Nutt, who now runs his own drugs panel.